Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
4,797 Dovepress* 4,042 460+ 548 4,502
PubMed Central* 0 295 167 295
Totals 4,042 755 715 4,797
*Since 1 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 0 7 10

View citations on PubMed Central and Google Scholar